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Introduction
Telomeres are repetitive structures at the end of mammalian
chromosomes and together with associated proteins they protect
chromosome ends (1). In normal cells, a progressive telomere
shortening accompany each cycle of replication (2) and there is
a well-established gradual loss of telomere length in human
peripheral blood with increasing age (3-7). In addition, most (8-
10) but not all studies (11, 12) have shown a positive
association between telomere length and overall survival in
humans. Evidence accumulates that telomere shortening
reflects lifestyle and predicts remaining lifespan by a direct
biological effect. More recent findings suggest that telomere
length may not be a strong biomarker of survival in older
individuals, but may be an informative biomarker of healthy
aging (13). However, there are few longitudinal data examining
the prognostic value of leukocyte telomere length in the context
of other health variables such as comorbidity, functional,
nutritional and cognitive status. 
Thus, we sought to investigate the relationship between
leukocyte telomere length and mortality among a population of
very old, acutely ill patients discharged from a geriatric hospital
in a prospective cohort study and to determine whether
leukocyte telomere length provides incremental prognostic
value beyond existing other markers of risk.
Methods
Patients and data collection
We carried out a prospective study in a 300-acute bed
geriatric hospital (HOGER) where 22.7% are direct admission
from the community, 54.0% are referred by the emergency unit
and 23.3% are transferred from other divisions of Geneva
University Hospitals, Switzerland. Patients and data collection
have been described elsewhere (14-16). Briefly, a
representative sample of all patients aged 75 years and over,
consecutively admitted in 2004 were selected by
randomization, with a sampling fraction of 30% using a
computer generated randomization table. The local ethics
committee approved the protocol, and patients, their families or
legal representatives provided signed written informed consent.
Demographic data for the patients studied did not significantly
differ from all patients admitted to HOGER at the same period.
Our sample was therefore representative of all patients admitted
to this hospital, demonstrating the reliability of the
randomization procedure used in this study.
Medical history was recorded on a standardized form and the
same geriatrician carried out a comprehensive geriatric
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assessment on all patients. Annual follow-up was carried out
with the same assessment over a five-year period.
Sociodemographic data 
The data recorded included age, sex, native language, marital
status, living arrangement and educational level. 
Telomere length measurements 
Telomere length were determined as a function of
fluorescence intensity, using an FITC-labeled peptide nucleic
acid (PNA) probe (FITC-coupled) supplied with the telomere
PNA /FITC for flow cytometry kit by DAKO (http://www.
dakousa.com/prod_downloadpackageinsert.pdf?objectid=11479
1002). 
In situ hybridization: Lymphocytes were prepared for
hybridization in the presence of hybridization solution without
probe or in hybridization solution containing fluorescein-
conjugated PNA telomere probe, as described in Hultdin et al.
(17). Flow cytometry: Labelled cells were analyzed by flow
cytometry. Homogeneous lymphocyte subpopulations were
identified. DNA was labelled with DAPI to identify cell
populations with similar DNA content, with gating on the G1
population. FITC-labelled cells were counted in the gated
population. As an internal control, telomere length was
measured in a standard cell line (HL60), which allowed
normalizing the flow cytometric measurements with respect to
day to day variations. Image analysis was performed with the
same flow cytometer (FACS, Fluorescence Activated Cell
Sorting; Partec PAS Flow Cytometer Galaxy, USA) in each
case. Mean telomere fluorescence intensity was calculated as
the difference between the fluorescence signal obtained with
samples hybridized with the Telomere PNA Probe/FITC and
the fluorescence signal obtained with a sample of the same cells
incubated with the hybridization solution without probe.
Results are expressed as telomere length index, which is the
fluorescent signal obtained in the patient cells divided by the
fluorescent signal of the control HL-60 cells. Thus, a telomere
length index of 1 indicates a telomere length in the patient
sample identical to the one observed in HL-60 cells. The intra-
assay coefficient of variance of this measurement was less than
2%. 
Nutritional assessment 
Body mass index (BMI kg/m2) was determined and the short
version of the Mini Nutritional Assessment (MNA) (score
ranging from 0 to 14, ≥ 12 being normal) administered on
admission, by the same nurse in each case (18). The reference
period for the MNA was two weeks before admission. Albumin
blood level (g/l) was measured by bromocresol purple dye-
binding method.
Functionality
Base and Instrumental Activities of Daily Living (ADL,
IADL) (19, 20) scores were determined as a function of patient
status two weeks before admission, based on the patient's
medical history or information supplied by an informal or
formal carer. 
Assessment of Comorbidity
From our previous work on this cohort (21) the best
prognostic predictor of 5-year mortality was the Geriatric Index
of Comorbidity (GIC) (22) class 4 multiplying the risk of death
by 4, thus we used this comorbidity score in this study. The
same geriatrician calculated this score for each patient, via an
extensive review of the patient's medical records and
administrative data for diagnoses established at or before
enrolment in this study and by standardized interviews with
patients and surrogates. The GIC classifies patients into four
classes of increasing somatic comorbidity. 
Cognitive diagnosis 
The same neuropsychologist assessed all subjects for clinical
dementia, The MMSE (23) and the Short Cognitive Evaluation
Battery were used (24, 25). Based on screening results, the
neuropsychologist then carried out a comprehensive
standardized neuropsychological assessment to determine the
etiology and severity of clinical dementia, as previously
described (14, 15). The formal clinical criteria used for
diagnosis were those of the DSM IV-TR (26), NINCDS-
ADRDA (27) and NINDS-AIREN (28). Cerebral imaging was
also carried out.
Outcome 
The outcome of interest was death by December 31, 2009,
that means an average 60 months (five years) of follow-up.
This information was obtained through yearly phone calls to the
patient, his family and/or his general practitioner. Mortality
data was also confirmed through access to the population
registrar of the State of Geneva. 
Statistical methods
We checked the normality of the data distribution with
skewness and kurtosis tests, and carried out standard
transformations to normalise non-Gaussian variables. Data for
continuous variables are presented as means ± 1 standard
deviation (SD).
First, we measured the univariate relationship between each
independent variable and 5-year mortality. We used Cox
proportional hazards models to take into account the time to the
event. The independent variables assessed as possible
predictors included age, sex, telomere length, nutritional and
functional status before admission (MNA, ADL and IADL
scores), albumin level and BMI at admission, comorbidity score
and cognitive diagnosis (normal or demented). We also used
Kaplan-Meier survival curves to examine the performance of
the independent variables over time. We then entered all
independent variables and 5-year mortality as dependent
variable in multivariate Cox regression. Hazards ratios (HR)
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along with their 95% confidence intervals (CI) were calculated.
Continuous variables were either included as such or
dichotomized, using the lower cut-off value (MNA, ADL and
IADL). As it was not possible to normalize telomere length and
BMI scores, they were categorized into tertiles for telomere
length (lower tertile ≤ 0.49 (95% CI 0.44-0.52), reference
tertile: 0.49-0.77 and upper tertile > 0.77 (95% CI 0.72-0.82))
and quartiles for BMI (< 20 kg/m2, 20-25 kg/m2 = reference,
25-30 kg/m2 and > 30 kg/m2). The proportional-hazards
assumption was successfully tested for telomere length based
on Schoenfeld residuals. Pseudo R-squared (R2) which provides
information on the amount of variance explained by the model
were computed using the Stata “str2ph” command based on the
Royston's modification of O'Quigley, Xu & Stare's
modification of Nagelkerke's R2 statistic for proportional-
hazards models with censored survival data (29). The
comorbidity score applied, the GIC is predefined into four
classes. As there were only 2% of the patients classified as
class 1 by the GIC, they were combined with class 2 for the
analysis and considered as the standard. Statistical analyses
were performed with Stata software version 11, TX, US.
Results
556 patients were randomized, 523 were successfully
enrolled and 496 survived to hospital discharge (27 died during
the hospitalization), 444 patients had full data and were
included in this study (mean age 85.3 ± 6.7; 74 % women). Of
the 444 patients, 263 died during the five years after discharge
(59.2%). The distribution of patients according to sex, telomere
length, BMI, MNA, albumin level, ADL, IADL, comorbidity
score and cognitive function on baseline and those who died
after 5 years of follow-up are described in Table 1. 
Univariate and multiple Cox proportional hazards
modeling (Table 2) 
In univariate analysis, 5 year-mortality was significantly
associated with age, each supplementary year added 7% to the
risk of death (R2 = 9.5%, HR = 1.07, 95% CI = 1.05 - 1.09);
being a men increased the risk by 1.5 fold (R2 = 1.9%, HR =
1.52, 95% CI = 1.17 - 1.98). The telomere length, the cognitive
status and the MNA score were not predictor of the outcome. 
The best prognostic predictor was the GIC class 4 (R2 =
8.8%, HR = 1.07HR = 3.85, 95% CI = 2.29 - 6.47). After 5
years, approximately 80% of the high score patients were
already deceased, compared with less than 40% in the lowest
scores.
The albumin level (R2 = 1.5%, HR = 0.97, 95% CI = 0.95 -
0.99); the ADL (R2 = 2.3%, HR = 0.84, 95% CI = 0.76 - 0.93)
and IADL (R2 = 5.9%, HR = 0.87, 95% CI = 0.82 - 0.92) were
negatively associated, that means lower albumin levels and
more dependence in based and instrumental activities of daily
living were associated with greater mortality. Each
supplementary gram of albumin added 3% of additional
protective risk against death. Curiously, obesity (BMI > 30: R2
= 1.6%, HR = 0.55, 95% CI = 0.35 - 0.86) was significantly
associated with a half lower mortality risk compared to BMI
between 20 and 25 considered as the reference level. Kaplan-
Meier survival curves of the independent risk factors are shown
in figure 1. 
Table 1 
Distribution of patients according to sex, telomere length, BMI,
MNA, albumin level, ADL, IADL, comorbidity score and
cognitive function at baseline (n = 444) and those who died (n
= 263) after 5 years of follow-up
Patients included Patients dead after 
at baseline 5 years of follow-up
N % N %
Age (mean ± SD) 85.2 ± 6.7 - 86.8 ± 6.5 -
Female/Male 328/116 74.0/26.0 183/80 69.6/30.4
Telomere length 
(median ± iqr, 0.63 ± 0.49)
lower tertile (≤ 0.49) 147 33.1 109 41.4
medium tertile (0.49-0.77) 147 33.1 87 33.1
upper tertile (> 0.77) 150 33.8 67 25.5
BMI (kg/m2)
< 20 94 21.2 62 23.6
20-25 179 40.3 109 41.5
25-30 115 25.9 69 26.2
> 30 56 12.6 23 8.7
MNA
< 12 337 75.9 200 76.0
≥ 12 107 24.1 63 24.0
Albumin level g/l (median ± iqr, 33 ± 8)
≤ median 240 54.0 152 57.8
> median 204 46.0 111 42.2
ADL (median ± iqr; 5 ± 1)
≤ median 106 23.9 75 28.5
> median 338 76.1 188 71.5
IADL (median ± iqr; 4 ± 3)
≤ median 166 37.4 121 46.0
> median 278 62.6 142 54.0
GIC
Class 1+2 43 9.7 18 6.8
Class 3 310 69.8 174 66.2
Class 4 91 20.5 71 27.0
Demented/cognitively normal 190/254 42.8/57.2 121/142 46.0/54.0
BMI = body mass index, MNA = mini nutritional assessment, ADL = base activities of
daily living, IADL = instrumental activities of daily living, GIC = geriatrics index of
comorbidity, SD = standard deviation, iqr = inter quartile range. Bold entries = relevant
results.
When all variables were included in the full model while
adjusting for age and sex (R2 = 21.4%), the GIC class 4 (HR =
2.45, 95% CI = 1.40 - 4.28) remained the best predictor
independently associated with 5-year mortality followed by the
IADL (HR = 0.91, 95% CI = 0.84 - 0.98), the albumin level
(HR = 0.97, 95% CI = 0.95 - 1.00); the BMI > 30 (HR = 0.60,
95% CI = 0.37 - 0.98); age (HR = 1.06, 95% CI = 1.03 - 1.08)
and sex (HR = 1.69, 95% CI = 1.27 - 2.24). 
Discussion
The purpose of this paper was to evaluate the weight of a
biological predictor (telomere length) alone and compared to
other well known health predictors of 5-year mortality after
discharge of very elderly patients hospitalized in acute care. It
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was hypothesized that poor health variables exceed biological
factors like telomere length measure. This study confirmed the
importance of disability, comorbidity and malnutrition as
specific independent predictors in a very old population. One of
the main strengths of this study was the standardized
comprehensive assessment: the same geriatrician scored the
presence and the extent of comorbidity for all patients, the same
neuropsychologist carried out a systematic, complete
neuropsychological assessment of all the included patients,
increasing the accuracy of cognitive diagnosis, the same nurse
scored functional and nutritional tools and finally the same
biologist assessed the leukocyte telomere length. 
Several studies have examined telomere length as
determinant of mortality in the elderly. There is considerable
inconsistency in the current literature. Some reports have
shown associations of shorter telomere length with lower
survival: Cawthon and colleagues (9), in their study of
individuals 60 years old or older, demonstrated that the overall
mortality rate of persons with short telomeres was nearly
double that of individuals with long telomeres; Bakaysa et al.
(30) reported that twins with shorter telomere length have three
times the risk of death compared with their co-twins with
longer telomere length. In contrast other studies showed no
association between leukocyte telomere length and survival in
older individuals’ aged more than 85 years (11, 12). More
recently, Terry et al. had examined telomere length in
centenarians in good health versus poor health. Healthy
centenarians had significantly longer telomeres than did
unhealthy centenarians (p = 0.0475) (31). They have
demonstrated that investigations of the association between
telomere length and exceptional longevity must take into
account the health status of the individuals and have raised the
possibility that perhaps it is not exceptional longevity but one’s
function and health that may be associated with telomere
length. Our results confirmed this hypothesis.
In our population of very old patients, a 5-year mortality rate
of almost 60% was found after discharge. This rate was similar
to that reported in previous studies. Age per se is a well-known
negative prognostic risk factor for death and explained almost
10% of the variance of the outcome in this study. Nonetheless,
higher comorbidity, poor functional and nutritional status were
factors that negatively affected survival. Similarly to our
results, previous studies have shown that worse functional
status prior to and at hospital admission is associated with a
higher short and long-term mortality (32, 33) as well as higher
comorbidity scores and worse nutritional status (34, 35). 
Curiously, in this study, the univariate model shows only a
trend regarding dementia as a predictor of 5-year mortality.
This trend had completely disappeared when all the variables
were added in the full model. On the contrary, many studies
have examined survival in relation to dementia and the majority
has reported that dementia increases the risk of death compared
Table 2 
Univariate and full multiple Cox regression predicting 5-year mortality (n=444). All independent variables are continuous unless
otherwise specified
Univariate Cox regression Full Multiple Cox regression
Outcome Independent variables
Crude HR 95% CI p R2 (%) Adjusted HR 95% CI p R2 (%)
Death at 60 months 
(n=263) 21.4
Age 1.07 1.05 - 1.09 <0.001 9.5 1.06 1.03 - 1.08 <0.001
Sex male 1.52 1.17 - 1.98 0.002 1.9 1.69 1.27 - 2.24 <0.001
Telomere length 0.2
lower tertile 1.04 0.76 -1.40 0.815 0.75 0.55 - 1.04 0.082
medium tertile 1.00 -- --
upper tertile 1.06 0.77 - 1.44 0.726 0.95 0.69 - 1.31 0.771
BMI (kg/m2) 1.6
< 20 1.15 0.71 - 3.62 0.369 1.17 0.83 - 1.65 0.383
20-25 1.00 -- -- 1.00 -- --
25-30 0.96 1.82 - 7.53 0.791 0.86 0.62 - 1.19 0.364
> 30 0.55 0.35 - 0.86 0.009 0.60 0.37 - 0.98 0.042
MNA 0.5
0.96 0.92 - 1.00 0.071 0.99 0.94 - 1.05 0.734
Albumin (g/l) 1.5
0.97 0.95 - 0.99 0.007 0.97 0.95 - 1.00 0.031
ADL 2.3
0.84 0.76 - 0.93 0.001 1.00 0.87 - 1.16 0.949
IADL 5.9
0.87 0.82 - 0.92 <0.001 0.91 0.84 - 0.98 0.015
GIC 8.8
Class 1+2 1.00 -- --
Class 3 1.64 1.01 - 2.66 0.047 1.24 0.75 - 2.06 0.389
Class 4 3.85 2.29 - 6.47 <0.001 2.45 1.40 - 4.28 0.002
Demented vs cognitively normal 1.27 1.00 - 1.62 0.053 0.6 0.88 0.66 - 1.16 0.365
BMI = body mass index, MNA = mini nutritional assessment, ADL = base activities of daily living, IADL = instrumental activities of daily living, GIC = geriatrics index of comorbidity.
Bold entries = relevant results.
to no dementia (36, 37). Recently, a Danish population-based
cohort study (14 years of follow-up) involving 3,065
nondemented and 234 demented at baseline , showed that the
hazard ratio of death (95% confidence interval) increased from
1.82 (1.55-2.14) for the very mildly demented to 9.52 (6.60-
13.74) for the severely demented subjects (38). The majority of
these studies are population based and have examined survival
from the time of diagnosis of dementia, whereas our study,
which was not designed for this purpose, was based on a
selected group in a clinical setting and 42% of the cohort had
dementia diagnosis at baseline. 
Figure 1
Kaplan-Meier survival curves according to the observed
variables. Marks represent censored observations
Telomere length (lower tertile: black line; medium tertile: long dashed line; upper tertile:
dashed line); GIC = geriatrics index of comorbidity (class 1-2: black line; 3: long dashed
line; 4: dashed line); IADL = instrumental activities of daily living, ADL = base activities
of daily living and Albumin = albumin level g/l (≤ median: black line; > median: long
dashed line); BMI = body mass index (kg/m2) (< 20: black line; 20-25: long dashed line;
25-30: dashed line; > 30 short dashed line).
Our study has some limitations. First, since it focused on
hospitalized elderly patients, it is likely that it is difficult to
generalize its conclusions to institutionalized and community
dwelling subjects. Second, only one center was involved so the
results have to be confirmed in others centers. Third the
enrolled patients were very old, acutely ill, and had a high
burden of comorbidities. 
In conclusion, in this cohort of oldest old, neither leukocyte
telomere length nor the presence of dementia are predictors of
5-year survival whereas the weight of multiple comorbidity
conditions, nutritional and functional impairment are. Hospital
discharge planning and prognosis can help physicians and
family members plan for the care of patients who may be at
increased risk of adverse outcomes in the coming years,
especially regarding discussions of goals of care, treatment
preferences, advance planning, and clinical therapeutic options.
Hospitalization therefore may present a key trigger point to
identify persons at greatest risk for mortality in the years
following discharge.
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